Document:

Exhibit 4.1

 

THIS
SECURITY HAS NOT BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON
AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY
NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO AN AVAILABLE EXEMPTION
FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND IN ACCORDANCE WITH APPLICABLE STATE
SECURITIES LAWS. THIS SECURITY MAY BE PLEDGED IN CONNECTION WITH A BONA FIDE MARGIN ACCOUNT WITH A REGISTERED BROKER-DEALER OR OTHER
LOAN WITH A FINANCIAL INSTITUTION THAT IS AN “ACCREDITED INVESTOR” AS DEFINED IN RULE 501(a) UNDER THE SECURITIES ACT OR
OTHER LOAN SECURED BY SUCH SECURITIES.

 

THE
TRANSFER OF THIS WARRANT IS RESTRICTED AS DESCRIBED HEREIN.

 

H-CYTE,
INC.

 

Warrant
for the Purchase of Shares of Common Stock, par value $0.001 per share

 

Original
Issue Date: ___________, 2022

 

THIS
CERTIFIES that, for value received, [Name of Holder], whose address is [______] (the “Holder”), is entitled to subscribe
for and purchase from H-Cyte, Inc., a Nevada corporation (the “Company”), upon the terms and conditions set forth
herein, up to the number of Warrant Shares at a purchase price per share equal to $0.014 per share (the “Exercise Price”),
subject to the provisions and upon the terms and conditions set forth herein. This Warrant was issued to the Holder in connection with
that certain warrant inducement letter dated as of the date hereof between the Company and the Holder.

 

The
number of shares of Common Stock issuable upon exercise of this Warrant (the “Warrant Shares”) and the Exercise Price
may be adjusted from time to time as hereinafter set forth.

 

1.
Exercise Period. Subject to the terms and conditions set forth herein, this Warrant may be exercised at any time or from time
to time during the period commencing on the date of issuance and continuing until the fifth (5th) anniversary of the issuance date (the
“Exercise Period”).

 

2.
Procedure for Exercise; Effect of Exercise.

 

(a)
Cash Exercise. This Warrant may be exercised, in whole or in part, by the Holder during normal business hours on any business
day during the Exercise Period by (i) the presentation and surrender of this Warrant to the Company at its principal office (or such
other office or agency of the Company as it may designate by notice in writing to the Holder at the address of the Holder appearing on
the books of the Company) along with a duly executed Notice of Exercise (in the form attached hereto) specifying the number of Warrant
Shares to be purchased, and (ii) delivery of payment to the Company of the Exercise Price for the number of Warrant Shares specified
in the Notice of Exercise by cash, wire transfer of immediately available funds to a bank account specified by the Company, or by certified
or bank cashier’s check.

 

    	 

    	 

    

 

(b)
Cashless Exercise. If the Warrant has been outstanding for six (6) months and there is no effective registration statement including
the Warrant Shares, this Warrant may also be exercised by the Holder through a cashless exercise, as described in this Section 2(b).
In such case, this Warrant may be exercised, in whole or in part, by the Holder during normal business hours on any business day during
the Exercise Period by the presentation and surrender of this Warrant to the Company at its principal office (or such other office or
agency of the Company as it may designate by notice in writing to the Holder at the address of the Holder appearing on the books of the
Company) along with a duly executed Notice of Exercise specifying the number of Warrant Shares to be applied to such exercise. The number
of shares of Common Stock to be issued upon exercise of this Warrant pursuant to this Section 2(b) shall equal the value of this Warrant
(or the portion thereof being canceled) computed as of the date of delivery of this Warrant to the Company using the following formula:

 

	 	X
    = 	Y(A-B)
    A

 

Where:

 

	 	X
    = the number of shares of Common Stock to be issued to Holder under this Section 2(b);
	 	Y
    = the number of Warrant Shares identified in the Notice of Exercise as being applied to the subject exercise;
	 	A
    = the Current Market Price on such date; and
	 	B
    = the Exercise Price on such date.

 

For
purposes of this Section 2(b), Current Market Price shall have the definition provided in Section 6(g).

 

The
Company acknowledges and agrees that this Warrant was issued on the date set forth at the end of this Warrant. Consequently, the Company
acknowledges and agrees that, if the Holder conducts a cashless exercise pursuant to this Section 2(b), the period during which the Holder
held this Warrant may, for purposes of Rule 144 promulgated under the Securities Act of 1933, as amended (the “Securities Act”),
be “tacked” to the period during which the Holder holds the Warrant Shares received upon such cashless exercise.

 

(c)
Effect of Exercise. Upon receipt by the Company of this Warrant and a Notice of Exercise, together with proper payment of the
Exercise Price, as provided in this Section 2, the Company agrees that such Warrant Shares shall be deemed to be issued to the Holder
as the record holder of such Warrant Shares as of the close of business on the date on which this Warrant has been surrendered and payment
has been made for such Warrant Shares in accordance with this Warrant and the Holder shall be deemed to be the holder of record of the
Warrant Shares, notwithstanding that the stock transfer books of the Company shall then be closed or that certificates representing such
Warrant Shares shall not then be actually delivered to the Holder. A stock certificate or certificates for the Warrant Shares specified
in the Notice of Exercise shall be delivered to the Holder as promptly as practicable, and in any event within seven (7) business days,
thereafter. The stock certificate(s) so delivered shall be in any such denominations as may be reasonably specified by the Holder in
the Notice of Exercise. If this Warrant should be exercised in part only, the Company shall, upon surrender of this Warrant for cancellation,
execute and deliver a new Warrant evidencing the right of the Holder to purchase the balance of the Warrant Shares subject to purchase
hereunder.

 

    	2

    	 

    

 

3.
Registration of Warrants; Transfer of Warrants. Any Warrants issued upon the transfer or exercise in part of this Warrant shall
be numbered and shall be registered in a Warrant Register as they are issued. The Company shall be entitled to treat the registered holder
of any Warrant on the Warrant Register as the owner in fact thereof for all purposes and shall not be bound to recognize any equitable
or other claim to or interest in such Warrant on the part of any other person, and shall not be liable for any registration or transfer
of Warrants which are registered or to be registered in the name of a fiduciary or the nominee of a fiduciary unless made with the actual
knowledge that a fiduciary or nominee is committing a breach of trust in requesting such registration or transfer, or with the knowledge
of such facts that its participation therein amounts to bad faith. This Warrant shall be transferable only on the books of the Company
upon delivery thereof duly endorsed by the Holder or by its duly authorized attorney or representative, or accompanied by proper evidence
of succession, assignment, or authority to transfer. In all cases of transfer by an attorney, executor, administrator, guardian, or other
legal representative, duly authenticated evidence of his or its authority shall be produced. Upon any registration of transfer, the Company
shall deliver a new Warrant or Warrants to the person entitled thereto. This Warrant may be exchanged, at the option of the Holder thereof,
for another Warrant, or other Warrants of different denominations, of like tenor and representing in the aggregate the right to purchase
a like number of Warrant Shares, upon surrender to the Company or its duly authorized agent.

 

4.
Restrictions on Transfer.

 

(a)
The Holder, as of the date of issuance hereof, represents to the Company that such Holder is acquiring the Warrants for its own account
for investment purposes and not with a view to the distribution thereof or of the Warrant Shares. Notwithstanding any provisions contained
in this Warrant to the contrary, this Warrant and the related Warrant Shares shall not be transferable except pursuant to the proviso
contained in the following sentence or upon the conditions specified in this Section 4, which conditions are intended, among other things,
to insure compliance with the provisions of the Securities Act and applicable state law in respect of the transfer of this Warrant or
such Warrant Shares. The Holder by acceptance of this Warrant agrees that the Holder will not transfer this Warrant or the related Warrant
Shares prior to delivery to the Company of an opinion of the Holder’s counsel (as such opinion and such counsel are described in
Section 4(b) hereof) or until registration of such Warrant Shares under the Securities Act has become effective or after a sale of such
Warrant or Warrant Shares has been consummated pursuant to Rule 144 or Rule 144A under the Securities Act; provided, however,
that the Holder may freely transfer this Warrant or such Warrant Shares (without delivery to the Company of an opinion of counsel) (i)
to one of its nominees, affiliates or a nominee thereof, (ii) to a pension or profit-sharing fund established and maintained for its
employees or for the employees of any affiliate, (iii) from a nominee to any of the aforementioned persons as beneficial owner of this
Warrant or such Warrant Shares, (iv) to a qualified institutional buyer, so long as such transfer is effected in compliance with Rule
144A under the Securities Act, or (v) to an accredited investor (as such term is defined in Regulation D under the Securities Act).

 

    	3

    	 

    

 

(b)
The Holder, by its acceptance hereof, agrees that prior to any transfer of this Warrant or of the related Warrant Shares (other than
as permitted by Section 4 hereof or pursuant to a registration under the Securities Act), the Holder will give written notice to the
Company of its intention to effect such transfer, together with an opinion of such counsel for the Holder as shall be reasonably acceptable
to the Company, to the effect that the proposed transfer of this Warrant and/or such Warrant Shares may be effected without registration
under the Securities Act. Upon delivery of such notice and opinion to the Company, the Holder shall be entitled to transfer this Warrant
and/or such Warrant Shares in accordance with the intended method of disposition specified in the notice to the Company.

 

(c)
Each stock certificate representing Warrant Shares issued upon exercise or exchange of this Warrant and any other securities issued in
respect of the Warrant Shares upon any stock split, stock dividend, recapitalization, merger, consolidation or similar event, shall bear
the following legend (unless the opinion of counsel referred to in Section 4 states such legend is not required) in addition to any other
agreement to which the Holder is subject:

 

“THIS
SECURITY HAS NOT BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON
AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY,
MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO AN AVAILABLE
EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND IN ACCORDANCE WITH APPLICABLE
STATE SECURITIES LAWS. THIS SECURITY MAY BE PLEDGED IN CONNECTION WITH A BONA FIDE MARGIN ACCOUNT WITH A REGISTERED BROKER-DEALER OR
OTHER LOAN WITH A FINANCIAL INSTITUTION THAT IS AN “ACCREDITED INVESTOR” AS DEFINED IN RULE 501(a) UNDER THE SECURITIES ACT
OR OTHER LOAN SECURED BY SUCH SECURITIES.”

 

The
Holder understands that the Company may place, and may instruct any transfer agent or depository for the Warrant Shares to place, a stop
transfer notation in the securities records in respect of the Warrant Shares.

 

5.
Reservation of Shares. The Company shall at all times during the Exercise Period reserve and keep available out of its authorized
and unissued Common Stock, solely for the purpose of providing for the exercise of the rights to purchase all Warrant Shares granted
pursuant to the Warrants, such number of shares of Common Stock as shall, from time to time, be sufficient therefor. The Company covenants
that all shares of Common Stock issuable upon exercise of this Warrant, upon receipt by the Company of the full Exercise Price therefor,
and all shares of Common Stock issuable upon conversion of this Warrant, shall be validly issued, fully paid, non-assessable, and free
of preemptive rights, and free from all taxes, claims, liens, charges and other encumbrances.

 

    	4

    	 

    

 

6.
Certain Adjustments.

 

(a)
The Exercise Price shall be subject to adjustment from time to time as follows:

 

(i)
In the event that the Company shall (A) pay a dividend or make a distribution to all its stockholders, in shares of Common Stock, on
any class of capital stock of the Company or any subsidiary which is not directly or indirectly wholly owned by the Company, (B) split
or subdivide its outstanding Common Stock into a greater number of shares, or (C) combine its outstanding Common Stock into a smaller
number of shares, then in each such case the Exercise Price in effect immediately prior thereto shall be adjusted so that the Holder
of a Warrant thereafter surrendered for Exercise shall be entitled to receive the number of shares of Common Stock that such Holder would
have owned or have been entitled to receive after the occurrence of any of the events described above had such Warrant been exercised
immediately prior to the occurrence of such event. An adjustment made pursuant to this Section 6(a)(i) shall become effective immediately
after the close of business on the record date in the case of a dividend or distribution (except as provided in Section 6(e) below) and
shall become effective immediately after the close of business on the effective date in the case of such subdivision, split or combination,
as the case may be. Any shares of Common Stock issuable in payment of a dividend shall be deemed to have been issued immediately prior
to the close of business on the record date for such dividend for purposes of calculating the number of outstanding shares of Common
Stock under clauses (c) and (d) below.

 

(ii)
No adjustment in the Exercise Price shall be required unless the adjustment would require an increase or decrease of at least 1% in the
Exercise Price then in effect; provided, however, that any adjustments that by reason of this Section 6(a) are not required to
be made shall be carried forward and taken into account in any subsequent adjustment. All calculations under this Section 6(a) shall
be made to the nearest cent or nearest 1/100th of a share.

 

(iii)
The Company from time to time may reduce the Exercise Price by any amount for any period of time in the discretion of the Board of Directors.
A voluntary reduction of the Exercise Price does not change or adjust the Exercise Price otherwise in effect for purposes of this Section
6(a).

 

(iv)
In the event that, at any time as a result of an adjustment made pursuant to Section 6(a)(i) or 6(a)(ii) above, the Holder of any Warrant
thereafter surrendered for exercise shall become entitled to receive any shares of the Company other than shares of the Common Stock,
thereafter the number of such other shares so receivable upon exercise of any such Warrant shall be subject to adjustment from time to
time in a manner and on terms as nearly equivalent as practicable to the provisions with respect to the Common Stock contained in Section
6(a)(i) or 6(a)(ii) above, and the other provisions of this Section 6(a) with respect to the Common Stock shall apply on like terms to
any such other shares.

 

    	5

    	 

    

 

(b)
In case of any reclassification of the Common Stock (other than in a transaction to which Section 6(a)(i) applies), any consolidation
of the Company with, or merger of the Company into, any other entity, any merger of another entity into the Company (other than a merger
that does not result in any reclassification, conversion, exchange or cancellation of outstanding shares of Common Stock of the Company),
any sale or transfer of all or substantially all of the assets of the Company or any compulsory share exchange, pursuant to which share
exchange the Common Stock is converted into other securities, cash or other property, then lawful provision shall be made as part of
the terms of such transaction whereby the Holder of a Warrant then outstanding shall have the right thereafter, during the period such
Warrant shall be exercisable, to exercise such Warrant only for the kind and amount of securities, cash and other property receivable
upon the reclassification, consolidation, merger, sale, transfer or share exchange by a holder of the number of shares of Common Stock
of the Company into which a Warrant might have been able to exercise for immediately prior to the reclassification, consolidation, merger,
sale, transfer or share exchange assuming that such holder of Common Stock failed to exercise rights of election, if any, as to the kind
or amount of securities, cash or other property receivable upon consummation of such transaction subject to adjustment as provided in
Section 6(a) above following the date of consummation of such transaction. The provisions of this Section 6(d) shall similarly apply
to successive reclassifications, consolidations, mergers, sales, transfers or share exchanges.

 

(c)
If (i) the Company shall take any action which would require an adjustment in the Exercise Price pursuant to Section 6(a); (ii) the Company
shall authorize the granting to the holders of its Common Stock generally of rights, warrants or options to subscribe for or purchase
any shares of any class or any other rights, warrants or options; (iii) there shall be any reclassification or change of the Common Stock
(other than a subdivision or combination of its outstanding Common Stock or a change in par value) or any consolidation, merger or statutory
share exchange to which the Company is a party and for which approval of any stockholders of the Company is required, or the sale or
transfer of all or substantially all of the assets of the Company; or (iv) there shall be a voluntary or involuntary dissolution, liquidation
or winding up of the Company; then, in each such case, the Company shall cause to be filed with the transfer agent for the Warrants and
shall cause to be mailed to each Holder at such Holder’s address as shown on the books of the transfer agent for the Warrants,
as promptly as possible, but at least 30 days prior to the applicable date hereinafter specified, a notice stating (A) the date on which
a record is to be taken for the purpose of such dividend, distribution or granting of rights, warrants or options, or, if a record is
not to be taken, the date as of which the holders of Common Stock of record to be entitled to such dividend, distribution or rights,
warrants or options are to be determined, or (B) the date on which such reclassification, change, consolidation, merger, statutory share
exchange, sale, transfer, dissolution, liquidation or winding-up is expected to become effective or occur, and the date as of which it
is expected that holders of Common Stock of record shall be entitled to exchange their shares of Common Stock for securities or other
property deliverable upon such reclassification, change, consolidation, merger, statutory share exchange, sale, transfer, dissolution,
liquidation or winding up. Failure to give such notice or any defect therein shall not affect the legality or validity of the proceedings
described in this Section 6(e).

 

(d)
Whenever the Exercise Price is adjusted as herein provided, the Company shall promptly file with the transfer agent for the Warrants
a certificate of an officer of the Company setting forth the Exercise Price after the adjustment and setting forth a brief statement
of the facts requiring such adjustment and a computation thereof. The Company shall promptly cause a notice of the adjusted Exercise
Price to be mailed to each Holder.

 

    	6

    	 

    

 

(e)
In any case in which Section 6(a) provides that an adjustment shall become effective immediately after a record date for an event and
the date fixed for such adjustment pursuant to Section 6(a) occurs after such record date but before the occurrence of such event, the
Company may defer until the actual occurrence of such event (i) issuing to the Holder of any Warrants exercised after such record date
and before the occurrence of such event the additional shares of Common Stock issuable upon such conversion by reason of the adjustment
required by such event over and above the Common Stock issuable upon such exercise before giving effect to such adjustment, and (ii)
paying to such holder any amount in cash in lieu of any fraction pursuant to Section 6(g).

 

(f)
In case the Company shall take any action affecting the Common Stock, other than actions described in this Section 6, which in the opinion
of the Board of Directors would materially adversely affect the exercise right of the Holders, the Exercise Price may be adjusted, to
the extent permitted by law, in such manner, if any, and at such time, as the Board of Directors may determine to be equitable in the
circumstances; provided, however, that in no event shall the Board of Directors be required to take any such action.

 

(g)
For the purpose of any computation under this Section 7, the “Current Market Price” per share of Common Stock shall
mean the VWAP of the Common Stock on the day in question. As used herein, “VWAP” means, for any date, the price determined
by the first of the following clauses that applies: (a) if the Common Stock is then listed or quoted on a Trading Market, the daily volume
weighted average price of the Common Stock for such date (or the nearest preceding date) on the Trading Market on which the Common Stock
is then listed or quoted as reported by Bloomberg L.P. (based on a Trading Day from 9:30 a.m. (New York City time) to 4:02 p.m. (New
York City time)), (b) if OTCQB or OTCQX is not a Trading Market, the volume weighted average price of the Common Stock for such date
(or the nearest preceding date) on OTCQB or OTCQX as applicable, (c) if the Common Stock is not then listed or quoted for trading on
OTCQB or OTCQX and if prices for the Common Stock are then reported in the “Pink Sheets” published by OTC Markets Group,
Inc. (or a similar organization or agency succeeding to its functions of reporting prices), the most recent bid price per share of the
Common Stock so reported, or (d) in all other cases, the fair market value of a share of Common Stock as determined by an independent
appraiser selected in good faith by the Holder and reasonably acceptable to the Company, the fees and expenses of which shall be paid
by the Company. “Trading Market” means the following markets or exchanges on which the Common Stock is listed or quoted
for trading on the date in question: the NYSE American LLC, the Nasdaq Capital Market, the Nasdaq Global Market, the Nasdaq Global Select
Market, the New York Stock Exchange, the OTC Bulletin Board, the OTCQX or OTCQB as maintained by OTC Markets, Inc.

 

(h)
The Company shall not be required to issue fractions of shares of Common Stock or other capital stock of the Company upon the exercise
of this Warrant. If any fraction of a share would be issuable on the exercise of this Warrant (or specified portions thereof), the Company
shall purchase such fraction for an amount in cash equal to the same fraction of the Current Market Price of such share of Common Stock
on the date of exercise of this Warrant.

 

    	7

    	 

    

 

7.
Transfer Taxes. The issuance of any shares or other securities upon the exercise of this Warrant, and the delivery of certificates
or other instruments representing such shares or other securities, shall be made without charge to the Holder for any tax or other charge
in respect of such issuance. The Company shall not, however, be required to pay any tax which may be payable in respect of any transfer
involved in the issue and delivery of any certificate in a name other than that of the Holder and the Company shall not be required to
issue or deliver any such certificate unless and until the person or persons requesting the issue thereof shall have paid to the Company
the amount of such tax or shall have established to the satisfaction of the Company that such tax has been paid.

 

8.
Loss or Mutilation of Warrant. Upon receipt of evidence reasonably satisfactory to the Company of the loss, theft, destruction,
or mutilation of any Warrant (and upon surrender of any Warrant if mutilated), and upon reimbursement of the Company’s reasonable
incidental expenses, the Company shall execute and deliver to the Holder thereof a new Warrant of like date, tenor, and denomination
in lieu of the lost, stolen, destroyed or mutilated Warrant or stock certificate provided, however, that, if the Company’s stock
is publicly traded, the Company may require the posting of a bond in an amount and nature as is customary and reasonable given the circumstances.

 

9.
No Rights as a Stockholder. The Holder of any Warrant shall not have, solely on account of such status, any rights of a stockholder
of the Company, either at law or in equity, or to any notice of meetings of stockholders or of any other proceedings of the Company,
except as provided in this Warrant.

 

10.
Governing Law. All questions concerning the construction, validity, enforcement and interpretation of this Warrant shall be governed
by and construed and enforced in accordance with the internal laws of the State of Nevada, without regard to the principles of conflicts
of law thereof.

 

11.
Notices. All notices and other communications hereunder shall be in writing and shall be deemed given if delivered personally,
by commercial delivery service, mailed by registered or certified mail (return receipt requested), sent via facsimile (with confirmation
of receipt) or electronic mail to the parties at the address for each party, as set forth in the introductory paragraph with respect
to the Holder and in the case of the Company, at 201 E. Kennedy Blvd, Suite 700, Tampa, Florida 33602.

 

12.
Purchaser Subscription Default. For the avoidance of doubt, this Warrant shall terminate immediately upon the occurrence of a
Purchaser Subscription Default with respect to the Holder and any Warrants Shares issued by the Company on, prior to or following the
occurrence of such a Purchaser Subscription Default with respect to the Holder shall be null and void, ab initio, without further
action or notice.

 

13.
Acceptance of Warrant. By acceptance of this Warrant, the Holder accepts and agrees to be bound by all of the terms and provisions
set forth herein.

 

*
* *

 

    	8

    	 

    

 

Issuance
date: ________________, 2022

 

	 	H-CYTE,
    INC.
	 	 	 
	 	By:
    	 
	 	Name:	Michael Yurkowsky
	 	Title:	Chief Executive Officer

 

Signature Page to Warrant
Issued to [PURCHASER]

 

    	 

    	 

    

 

FORM
OF ASSIGNMENT

 

(To
be executed by the registered holder if such holder desires to transfer the attached Warrant.)

 

FOR
VALUE RECEIVED, ___________________________ hereby sells, assigns, and transfers unto __________________ a Warrant to purchase the
Warrant Shares, together with all right, title, and interest therein, and does hereby irrevocably constitute and appoint
______________________________ attorney to transfer such Warrant on the books of the Company, with full power of substitution.

 

	 	Dated:	 

 

	 	By:
    	 
	 	 	Print
    Name
	 	 	 
	 	 	 
	 	 	Signature

 

The
signature on the foregoing Assignment must correspond to the name as written upon the face of this Warrant in every particular, without
alteration or enlargement or any change whatsoever.

 

    	 

    	 

    

 

	To:
    	H-Cyte,
    Inc.
	 	201
    E. Kennedy Blvd, Suite 700
	 	Tampa,
    FL 33602
	 	Attention:
    Chief Executive Officer

 

NOTICE
OF EXERCISE

 

The
undersigned hereby exercises his or its rights to purchase _______ Warrant Shares covered by the within Warrant and tenders payment herewith
in the amount of $_________ by [tendering cash or delivering a certified check or bank cashier’s check, payable to the order of
the Company] [surrendering ______ shares of Common Stock received upon exercise of the attached Warrant, which shares have a Current
Market Price equal to such payment] in accordance with the terms thereof, and requests that certificates for such securities be issued
in the name of, and delivered to:

 

_______________________________________

 

_______________________________________

 

_______________________________________

 

(Print
Name, Address and Social Security

or
Tax Identification Number)

 

and,
if such number of Warrant Shares shall not be all the Warrant Shares covered by the within Warrant, that a new Warrant for the balance
of the Warrant Shares covered by the within Warrant be registered in the name of, and delivered to, the undersigned at the address stated
below.

 

	 	Dated:	 

 

	 	By:
    	 
	 	 	Print
    Name
	 	 	 
	 	 	 
	 	 	Signature

 

	Address:Document

                                                                                                                                                                                EXHIBIT 4.10

DESCRIPTION OF REGISTERED SECURITIES
    As of February 25, 2022, Carriage Services, Inc. (the “Company,” “us,” “we,” or “our”) has one class of securities, our common stock, registered under Section 12 of the Securities Exchange Act of 1934, as amended.
Description of Common Stock
The following description of our common stock is a summary and does not purport to be complete. It is subject to and qualified in its entirety by reference to our Amended and Restated Certificate of Incorporation dated July 2, 1996 (as amended, the “Charter”), and our Second Amended and Restated Bylaws dated July 28, 2021 (as amended, the “Bylaws”), each of which are incorporated by reference as an exhibit to the Annual Report on Form 10-K of which this Exhibit 4.10 is a part. We encourage you to read our Certificate of Incorporation, our Bylaws, and the applicable provisions of the General Corporation Law of the State of Delaware (the “DGCL”) for additional information.
General
As of February 25, 2022, our authorized capital consisted of 80,000,000 shares of common stock, par value $.01, of which 15,326,738 shares were issued and outstanding, and 40,000,000 shares of preferred stock, par value $.01, of which no shares were issued and outstanding. Our common stock is quoted on the New York Stock Exchange under the symbol “CSV.”
The holders of our common stock are entitled to one vote for each share held on all matters submitted to a vote of common stockholders. Our common stock does not have cumulative voting rights, which means that the holders of a majority of the voting power of shares of common stock outstanding can elect all the directors, and the holders of the remaining shares will not be able to elect any directors. Each share of common stock is entitled to participate equally in dividends, if, as and when declared by our Board of Directors (the “Board”), and in the distribution of assets in the event of liquidation, subject in all cases to any prior rights of outstanding shares of preferred stock outstanding. Our shares of common stock have no preemptive rights, redemption rights or sinking fund provisions. 
Holders of our common stock are entitled to one vote per share in the election of directors and on all other matters submitted to a vote of stockholders. Such holders do not have the right to cumulate their votes in the election of directors. Holders of our common stock have no redemption or conversion rights, no preemptive or other rights to subscribe for our securities and are not entitled to the benefits of any sinking fund provisions. In the event of our liquidation, dissolution or winding-up, holders of our common stock are entitled to share equally and ratably in all of the assets remaining, if any, after satisfaction of all our debts and liabilities, and of the preferential rights of any series of preferred stock then outstanding. Subject to preferences that may be applicable to any then outstanding preferred stock, holders of our common stock are entitled to receive dividends when, as and if declared by the Board out of funds legally available therefor. 
Preferred Stock
Our preferred stock may be issued in series, and shares of each series will have such rights and preferences as may be fixed by the Board in the resolution authorizing the issuance of that particular series. In designating any series of preferred stock, the Board has the authority, without further action by the holders of our common stock, to fix the rights, dividend rate, conversion rights, rights and terms of redemption, and the liquidation preferences of that series of preferred stock, including: 

                                                                                                                                                                                EXHIBIT 4.10

												
	  		 	the title of the preferred stock;
	  		 	the maximum number of shares of the series;
	  		 	the dividend rate or the method of calculating the dividend, the date from which dividends will accrue and whether dividends will be cumulative;
	  		 	any liquidation preference;
	  		 	any optional redemption provisions;
	  		 	any terms for the conversion or exchange of the preferred stock for other securities of us or any other entity;
	  		 	any voting rights; and
	  		 	any other preferences and relative, participating, optional or other special rights or any qualifications, limitations or restrictions on the rights of the shares.

The authorized shares of preferred stock, as well as shares of common stock, are available for issuance without further action by our stockholders, unless stockholder action is required by the rules of any stock exchange or automated quotation system on which our securities are listed or traded. If the approval of our stockholders is not required for the issuance of shares of preferred stock or common stock, the Board may determine not to seek stockholder approval. 
Although the Board has no intention at the present time of doing so, it could issue a series of preferred stock that could, depending on the terms of that series, impede the completion of a merger, tender offer or other takeover attempt. The Board will make any determination to issue shares based on its judgment as to our best interests and the best interests of our stockholders. The Board, in so acting, could issue preferred stock having terms that could discourage an acquisition attempt, including a tender offer or other transaction that some, or a majority of, our stockholders might believe to be in their best interests or that might result in stockholders receiving a premium for their stock over the then current market price of the stock.
Anti-Takeover Provisions
DGCL
We are a Delaware corporation and are subject to Section 203 of the DGCL (“Section 203”). In general, Section 203 prevents an “interested stockholder” (defined generally as a person owning 15% or more of our outstanding voting stock) from engaging in a business combination with us for three years following the date that person becomes an interested stockholder, with the following exceptions: 
									
		 	before such date, the Board approved either the business combination or the transaction that resulted in the stockholder becoming an interested holder;
		 	upon completion of the transaction that resulted in the stockholder becoming an interested stockholder, the interested stockholder owned at least 85% of the voting stock of the corporation outstanding at the time the transaction began, excluding for purposes of determining the voting stock outstanding (but not the outstanding voting stock owned by the interested stockholder) those shares owned (i) by persons who are directors and also officers and (ii) employee stock plans in which employee participants do not have the right to determine confidentially whether shares held subject to the plan will be tendered in a tender or exchange offer; or
		 	on or after such date, the business combination is approved by the Board and authorized at an annual or special meeting of the stockholders, and not by written consent, by the affirmative vote of at least 66 2/3% of the outstanding voting stock that is not owned by the interested stockholder.

In general, Section 203 of the DGCL defines business combination to include the following: 
									
		 	any merger or consolidation involving the corporation and the interested stockholder;
		 	the sale, transfer, pledge or other disposition of 10% or more of the assets of the corporation involving the interested stockholder;
		 	subject to certain exceptions, any transaction that results in the issuance or transfer by the corporation of any stock of the corporation to the interested stockholder;
		 	any transaction involving the corporation that has the effect of increasing the proportionate share of the stock or any class or series of the corporation beneficially owned by the interested stockholder;  or
		 	the receipt by the interested stockholder of the benefit of any loss, advances, guarantees, pledges or other financial benefits by or through the corporation.

                                                                                                                                                                                EXHIBIT 4.10

In general, Section 203 of the DGCL defines an “interested stockholder” as an entity or person who, together with the person’s affiliates and associates, beneficially owns, or is an affiliate or associate of the corporation and within three years prior to the time of determination of interested stockholder status did own, 15% or more of the outstanding voting stock of the corporation.
Charter and Bylaw Provisions 
The Charter provides that the Board is divided into three classes. The directors of each class are elected for three-year terms, with the terms of the three classes staggered so that directors from a single class are elected at each annual meeting of stockholders. Stockholders may remove a director only for cause upon the vote of holders of at least 80% of voting power of the outstanding shares of common stock. In general, the Board, not the stockholders, has the right to appoint persons to fill vacancies on the Board. 
The Bylaws provide that special meetings of holders of common stock may be called only by the Board and that only such business proposed by the Board may be considered at special meetings of holders of common stock. 
The Bylaws provide that the only business (including election of directors) that may be considered at an annual meeting of holders of common stock, in addition to business proposed (or persons nominated to be directors) by the directors of the Company, is business proposed (or persons nominated to be directors) by holders of common stock who comply with the notice and disclosure requirements set forth in the Bylaws. In general, the Bylaws require that a stockholder give the Company notice of proposed business or nominations in advance of the annual meetings in accordance with the deadlines for such notices set forth therein. In general, the notice must also contain information about the stockholder proposing the business or nomination, the stockholder’s interest in the business, and (with respect to nominations for director) information about the nominee of the nature ordinarily required to be disclosed in public proxy solicitation statements. 
The DGCL provides generally that the affirmative vote of a majority of the shares entitled to vote on any matter is required to amend a corporation’s certificate of incorporation or bylaws, unless the corporation’s certificate of incorporation or bylaws requires a greater percentage. The Charter and the Bylaws provide that approval by the holders of at least 66.67% of the voting power of the outstanding voting stock of the Company is required to amend the provisions of the Charter and the Bylaws previously discussed, respectively, and certain other provisions.  The combination of our staggered Board, the lack of cumulative voting and the 66.67% stockholder voting requirements will make it more difficult for existing stockholders to replace the Board as well as for another party to obtain control of us by replacing the Board. Because the Board has the power to retain and discharge our officers, these provisions could also make it more difficult for existing stockholders or another party to effect a change in management. In addition, the authorization of undesignated preferred stock makes it possible for the Board to issue preferred stock with voting or other rights or preferences that could impede the success of any attempt to change control of us. 
These provisions may have the effect of deterring hostile takeovers or delaying changes in control or management of us. These provisions are intended to enhance the likelihood of continued stability in the composition of the Board and its policies and to discourage certain types of transactions that may involve an actual or threatened acquisition of us. These provisions are designed to reduce our vulnerability to an unsolicited acquisition proposal. The provisions also are intended to discourage certain tactics that may be used in proxy fights. However, such provisions could have the effect of discouraging others from making tender offers for our shares and, as a consequence, they also may inhibit fluctuations in the market price of our shares that could result from actual or rumored takeover attempts. Such provisions may also have the effect of preventing changes in our management.

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00341-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00341-of-00352.parquet"}]]